Large investments in SciLifeLab welcomed by Swedish Universities
30 April 2012
The presidents of the four Swedish universities behind the
Science for Life Laboratory (SciLifeLab) have welcomed large new
investments in life science research announced by the Swedish
The Swedish Minister for Education, Jan Björklund announced
earlier this month that in 2013 SciLifeLab will become a national
research institute for major research in molecular biosciences and
According to the government’s plan, SciLifeLab will grow to
employ about 1000 scientists and have a turnover of about SEK1
billion within a few years. In addition to the funding from the
government, the Knut and Alice Wallenberg foundation will invest
SEK220 million on technology laboratories in SciLifeLab and Astra
Zeneca intends to invest USD5-10 million annually for five years in
joint research projects within SciLifeLab.
“This is a great investment in the research at SciLifeLab that
the government, AstraZeneca and the Wallenberg foundation have
entrusted us with. We will take on this responsibility and work with
both a national and international perspective,“ said Harriet
Wallberg-Henriksson, president of Karolinska Institutet.
“Once fully developed, Sweden SciLifeLab will operate as a
national resource that accelerates Swedish biomedical research to
world class status. This investment will enable us to attract
leading scientists and innovative research to come to Sweden,” said
Eva Åkesson, president of Uppsala University.
“Together with the other universities, we can now build a
research environment ranking among the best in the world. The region
will thereby become attractive to the very best researchers and for
the establishment of new companies,” said Peter Gudmundson,
president of the Royal Institute of Technology, KTH.
“Stockholm University's internationally acclaimed research in
molecular bioscience and bioinformatics will continue to be central
to SciLifeLab and we welcome that the cooperation is now granted the
status of a national research institute,” said Kåre Bremer,
president of Stockholm University.
SciLifeLab is a joint venture between four universities;
Karolinska Institutet, the Royal Institute of Technology, Stockholm
University and Uppsala University.
The medical research focuses on investigating the molecular basis
of complex human diseases, and seeks to find biomarkers that can
help diagnose diseases and monitor their progress. If it can be
explained what actually happens in a person’s cells when they are
afflicted by cancer, diabetes or any other of our common diseases,
it should be possible to quickly come up with ideas for how to treat
Outcome results will improve and unnecessary costs can be
avoided. This research focus should also make SciLifeLab an
attractive partner for the pharmaceutical industry both in Sweden
For the environmental research program, SciLifeLab’s advanced
technology platforms will be utilised to create nationally and
internationally prominent environmental research programmes.
SciLifeLab has facilities both in Stockholm and in Uppsala.
The four universities that currently operate SciLifeLab will
continue to be key stakeholders in the new National Research
Institute Sweden Science for Life Laboratory.